Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial-Reference-Cited by-同舟云学术

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

Published:2010-11 Issue:11 Volume:11 Page:1057-1065
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Broyl Annemiek,Corthals Sophie L,Jongen Joost LM,van der Holt Bronno,Kuiper Rowan,de Knegt Yvonne,van Duin Mark,el Jarari Laila,Bertsch Uta,Lokhorst Henk M,Durie Brian G,Goldschmidt Hartmut,Sonneveld Pieter

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study;Harousseau;Haematologica,2006

2. Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics;Rosinol;J Clin Oncol,2007

3. First analysis of HOVON-65/GMMG-HD4 randomized phase III trial comparing bortezomib, adriamycine, dexamethasone (PAD) vs VAD as induction treatment prior to high dose melphalan (HDM) in patients with newly diagnosed multiple myeloma (MM);Sonneveld;Blood,2008

4. Delforge M, Bladé J, Dimopoulos MA, et al. Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol (in press).

5. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma;Jagannath;Br J Haematol,2004

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons;Neuropharmacology;2024-11

2. Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea;The Journal of Pain;2024-09

3. ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer;Journal of Clinical Oncology;2024-08-20

4. HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain;Inflammopharmacology;2024-05-18

5. Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach;Critical Reviews in Oncology/Hematology;2024-05